dc.contributor.author |
Huober, Jens |
|
dc.date.accessioned |
2015-11-11T13:42:32Z |
|
dc.date.available |
2015-11-11T13:42:32Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
0167-6806 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/66351 |
|
dc.language.iso |
en |
en |
dc.publisher |
Springer |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1007/s10549-015-3310-x |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20150901145020_01137 |
|
utue.publikation.seiten |
279-288 |
de_DE |
utue.personen.roh |
Erber, Ramona |
|
utue.personen.roh |
Gluz, Oleg |
|
utue.personen.roh |
Brunner, Nils |
|
utue.personen.roh |
Kreipe, Hans Heinrich |
|
utue.personen.roh |
Pelz, Enrico |
|
utue.personen.roh |
Kates, Ronald |
|
utue.personen.roh |
Bartels, Annette |
|
utue.personen.roh |
Huober, Jens |
|
utue.personen.roh |
Mohrmann, Svjetlana |
|
utue.personen.roh |
Moustafa, Zehra |
|
utue.personen.roh |
Liedtke, Cornelia |
|
utue.personen.roh |
Moebus, Volker |
|
utue.personen.roh |
Augustin, Doris |
|
utue.personen.roh |
Thomssen, Christoph |
|
utue.personen.roh |
Jaenicke, Fritz |
|
utue.personen.roh |
Kiechle, Marion |
|
utue.personen.roh |
Kuhn, Walther |
|
utue.personen.roh |
Nitz, Ulrike |
|
utue.personen.roh |
Harbeck, Nadia |
|
utue.personen.roh |
Hartmann, Arndt |
|
dcterms.isPartOf.ZSTitelID |
Breast Cancer Research and Treatment |
de_DE |
dcterms.isPartOf.ZS-Issue |
2 |
de_DE |
dcterms.isPartOf.ZS-Volume |
150 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |